In a significant turn of events, Patanjali Ayurved Ltd, led by Baba Ramdev, and its managing director Acharya Balkrishna, have formally apologized to the Supreme Court for their misleading advertisements, which were found to be in violation of advertising regulations.
Click Here to Join Whatsapp Group
The apology follows the apex court’s expression of dissatisfaction with the company’s advertising practices, prompting it to issue a notice to Patanjali last year. The case centered around multiple instances of false claims made by the company in its advertisements across various media platforms.
In their affidavit submitted to the Supreme Court, Patanjali and Acharya Balkrishna admitted to the misleading nature of some of their advertisements, acknowledging that they contravened the provisions outlined in the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and the Drugs and Cosmetics Act, 1940.
The affidavit stated, “The contemnors (Patanjali and Balkrishna) admit their mistake, tender an unconditional and unqualified apology to this Court and assure the Court that such mistakes will not be repeated in future.” Furthermore, Patanjali has assured the court of its commitment to adhere strictly to advertising laws and refrain from making any unsubstantiated or misleading claims in its future marketing endeavors.
The Supreme Court had taken a stern stance against Patanjali’s advertisements, particularly those that asserted the company’s products could cure severe illnesses such as cancer and COVID-19. The court emphasized the gravity of such misleading advertisements, emphasizing their potential to jeopardize public health and safety.
This case underscores the urgent need for heightened regulations and vigilant oversight of advertisements, particularly within the burgeoning ayurvedic and herbal products industry. Such measures are crucial for safeguarding consumers against false claims and ensuring their well-being.
